ABCB5 and melanoma: In addition, apoptosis, label-retention, frequency of ABCB5-positive cells and the expression of Wnt/β-catenin signaling target genes, MITF and c-MYC, were assessed in melanoma populations treated with compounds selected as either highly anti-clonogenic or highly cytotoxic.